Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.

NCT06553287 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: LNK01004 ointment 0.3%
DRUG: LNK01004 ointment 1.0%
DRUG: LNK01004 ointment 1.5%
DRUG: Vehicle BID

Sponsor

Lynk Pharmaceuticals Co., Ltd